Publication | Closed Access

Novel second generation analogs of eribulin. Part III: Blood–brain barrier permeability and in vivo activity in a brain tumor model

Neuro-oncologyDrug TargetingPart IiiBlood–brain BarrierBlood–brain Barrier PermeabilityMedicineBrain Tumor ModelTumor TargetingCerebral Blood FlowPharmacologyRadiation OncologyTumor BiologyCerebral Vascular Regulation